Dianthus Therapeutics, Inc.

NasdaqCM:DNTH Stock Report

Market Cap: US$661.2m

Dianthus Therapeutics, Inc. Company Information

Dianthus Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Dianthus Therapeutics, Inc.
  • Ticker: DNTH
  • Exchange: NasdaqCM
  • Founded: 2019
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$661.196m
  • Shares Outstanding: 29.60m
  • Website: https://dianthustx.com

Number of Employees

Location

  • Dianthus Therapeutics, Inc.
  • 7 Times Square
  • 43rd Floor
  • New York
  • New York
  • 10036
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DNTHNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDSep 2023
87EDB (Deutsche Boerse AG)YesCommon StockDEEURSep 2023

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 18:36
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.